- Previous Close
1.2500 - Open
0.0000 - Bid 1.2000 x --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 1.9800 - Volume
126,051 - Avg. Volume
27,380 - Market Cap (intraday)
1.369M - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It's lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
ovocabio.comRecent News: OVB.L
View MorePerformance Overview: OVB.L
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OVB.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OVB.L
View MoreValuation Measures
Market Cap
1.37M
Enterprise Value
-1.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.53
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
3.70%
Return on Equity (ttm)
-108.96%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.98M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
2.92M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
395.62k